Registro:

Referencias:

• Ashwell, J.D., Lu, F.W., Vacchio, M.S., Glucocorticoids in t cell development and function (2000) Annu Rev Immunol, 18, pp. 309-345
• Benedetti, S., Pirola, B., Poliani, P.L., Cajola, L., Pollo, B., Bagnati, R., Al, E., Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas (2003) Gene Ther, 10, pp. 188-192
• Brooks, W.H., Markesbery, W.R., Gupta, G.D., Roszman, T.L., Relationship of lymphocyte invasion and survival of brain tumor patients (1978) Ann Neurol, 4, pp. 219-224
• Carding, S.R., Egan, P.J., Gammadelta T cells: Functional plasticity and heterogeneity (2002) Nat Rev Immunol, 2, pp. 336-345
• Chiquet-Ehrismann, R., Chiquet, M., Tenascins: Regulation and putative functions during pathological stress (2003) J Pathol, 200, pp. 488-499
• Das, A., Banik, N.L., Patel, S.J., Ray, S.K., Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:bcl-2 ratio and preventing proteolytic activities (2004) Mol Cancer, 3, p. 36
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression (2003) Endocr Rev, 24, pp. 488-522
• De Palma, M., Venneri, M.A., Galli, R., Sergi Sergi, L., Politi, L.S., Sampaolesi, M., Naldini, L., Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors (2005) Cancer Cells, 8, pp. 211-226
• Dhodapkar, K.M., Cirignano, B., Chamian, F., Zagzag, D., Miller, D.C., Finlay, J.L., Steinman, R.M., Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion (2004) Int J Cancer, 109, pp. 893-899
• Ehtesham, M., Black, K.L., Yu, J.S., Recent progress in immunotherapy for malignant glioma: Treatment strategies and results from clinical trials (2004) Cancer Control, 11, pp. 192-207
• Elliott, R.L., Blobe, G.C., Role of transforming growth factor Beta in human cancer (2005) J Clin Oncol, 23, pp. 2078-2093
• Farin, A., Suzuki, S.O., Weiker, M., Goldman, J.E., Bruce, J.N., Canoll, P., Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis (2006) Glia, 53, pp. 799-808
• Ferrarini, M., Ferrero, E., Dagna, L., Poggi, A., Zocchi, M.R., Human gammadelta T cells: A nonredundant system in the immune-surveillance against cancer (2002) Trends Immunol, 23, pp. 14-18
• Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Al, E., Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation (2006) Nat Med, 12, pp. 235-239
• Fischer, I., Gagner, J.P., Law, M., Newcomb, E.W., Zagzag, D., Angiogenesis in gliomas: Biology and molecular pathophysiology (2005) Brain Pathol, 15, pp. 297-310
• Gagner, J.P., Law, M., Fischer, I., Newcomb, E.W., Zagzag, D., Angiogenesis in gliomas: Imaging and experimental therapeutics (2005) Brain Pathol, 15, pp. 342-363
• Galarneau, H., Villeneuve, J., Gowing, G., Julien, J.P., Vallières, L., Increased glioma growth in mice depleted of macrophages (2007) Cancer Res, 67, pp. 8874-8881
• Heiss, J.D., Papavassiliou, E., Merrill, M.J., Nieman, L., Knightly, J.J., Walbridge, S., Al, E., Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor (1996) J Clin Invest, 98, pp. 1400-1408
• Holash, J., Maisonpierre, P.C., Compton, D., Boland, P., Alexander, C.R., Zagzag, D., Al, E., Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF (1999) Science, 284, pp. 1994-1998
• Hu, B., Guo, P., Fang, Q., Tao, H.Q., Wang, D., Nagane, M., Al, E., Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2 (2003) Proc Natl Acad Sci USA, 100, pp. 8904-8909
• Hu, B., Jarzynka, M.J., Guo, P., Imanishi, Y., Schlaepfer, D.D., Cheng, S.Y., Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway (2006) Cancer Res, 66, pp. 775-783
• Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M.J., Cancer statistics, 2007 (2007) CA Cancer J Clin, 57, pp. 43-66
• Kaal, E.C., Vecht, C.J., The management of brain edema in brain tumors (2004) Curr Opin Oncol, 16, pp. 593-600
• Kabelitz, D., Wesch, D., Pitters, E., Zoller, M., Potential of human gammadelta T lymphocytes for immunotherapy of cancer (2004) Int J Cancer, 112, pp. 727-732
• Kerbel, R.S., Antiangiogenic therapy: A universal chemosensitization strategy for cancer? (2006) Science, 312, pp. 1171-1175
• Kishi, Y., Okudaira, S., Tanaka, M., Hama, K., Shida, D., Kitayama, J., Al, E., Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic Acid (2006) J Biol Chem, 281, pp. 17492-17500
• Kronenberg, M., Toward an understanding of NKT cell biology: Progress and paradoxes (2005) Annu Rev Immunol, 23, pp. 877-900
• MacHein, M.R., Kullmer, J., Ronicke, V., MacHein, U., Krieg, M., Damert, A., Al, E., Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells (1999) Neuropathol Appl Neurobiol, 25, pp. 104-112
• Morley, J.E., Thomas, D.R., Wilson, M.M., Cachexia: Pathophysiology and clinical relevance (2006) Am J Clin Nutr, 83, pp. 735-743
• Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., You, E., Al, E., Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 (2004) Cancer Cells, 6, pp. 507-516
• Papadopoulos, M.C., Saadoun, S., Binder, D.K., Manley, G.T., Krishna, S., Verkman, A.S., Molecular mechanisms of brain tumor edema (2004) Neuroscience, 129, pp. 1011-1020
• Pulkkanen, K.J., Yla-Herttuala, S., Gene therapy for malignant glioma: Current clinical status (2005) Mol Ther, 12, pp. 585-598
• Reardon, D.A., Wen, P.Y., Therapeutic advances in the treatment of glioblastoma: Rationale and potential role of targeted agents (2006) Oncologist, 11, pp. 152-164
• Reiss, Y., MacHein, M.R., Plate, K.H., The role of angiopoietins during angiogenesis in gliomas (2005) Brain Pathol, 15, pp. 311-317
• Robe, P.A., Nguyen-Khac, M., Jolois, O., Rogister, B., Merville, M.P., Bours, V., Dexamethasone inhibits the HSV-tk/ganciclovir bystander effect in malignant glioma cells (2005) BMC Cancer, 5, p. 32
• Scherpereel, A., Gentina, T., Grigoriu, B., Senechal, S., Janin, A., Tsicopoulos, A., Al, E., Overexpression of endocan induces tumor formation (2003) Cancer Res, 63, pp. 6084-6089
• Seino, K., Motohashi, S., Fujisawa, T., Nakayama, T., Taniguchi, M., Natural killer T cell-mediated antitumor immune responses and their clinical applications (2006) Cancer Sci, 97, pp. 807-812
• Seligman, A.M., Shear, M.J., Studies in Carcinogenesis. VIII. Experimental production of brain tumors in mice with methylcholanthrene (1939) Am J Cancer, 37, pp. 364-395
• Simmons, D.M., Arriza, J.L., Swanson, L.W., A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes (1989) J Histotechnol, 12, pp. 169-181
• Stupp, R., Hegi, M.E., Van Den Bent, M.J., Mason, W.P., Weller, M., Mirimanoff, R.O., Cairncross, J.G., Changing paradigms - An update on the multidisciplinary management of malignant glioma (2006) Oncologist, 11, pp. 165-180
• Sur, P., Sribnick, E.A., Patel, S.J., Ray, S.K., Banik, N.L., Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells (2005) Glia, 50, pp. 160-167
• Szatmari, T., Lumniczky, K., Desaknai, S., Trajcevski, S., Hidvegi, E.J., Hamada, H., Safrany, G., Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy (2006) Cancer Sci, 97, pp. 546-553
• Tait, C.R., Jones, P.F., Angiopoietins in tumours: The angiogenic switch (2004) J Pathol, 204, pp. 1-10
• Terabe, M., Berzofsky, J.A., Immunoregulatory T cells in tumor immunity (2004) Curr Opin Immunol, 16, pp. 157-162
• Thapar, K., Rutka, J.J.L., Brain edema, increased intracranial pressure, vascular effects and other epiphenomena of human brain tumors (1995) Brain Tumors: An Encyclopedic Approach., pp. 163-189. , In: A.H. Kaye, E.R. Laws (. eds), pp. Churchill Livingstone: Edinburgh; New York
• Valenzuela, D.M., Griffiths, J.A., Rojas, J., Aldrich, T.H., Jones, P.F., Zhou, H., Al, E., Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans (1999) Proc Natl Acad Sci USA, 96, pp. 1904-1909
• Villeneuve, J., Tremblay, P., Vallieres, L., Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation (2005) Cancer Res, 65, pp. 3928-3936
• Wen, P.Y., MacDonald, L., Conrad Gigas, D., Managment of non-neoplastic problems in brain tumor patients (2005) Cancer of the Nervous System., pp. 243-254. , In: P.M. Black, J.S. Loeffler (. eds), pp. Lippincott Williams & Wilkins: Philadelphia
• Wheeler, C.J., Black, K.L., Liu, G., Ying, H., Yu, J.S., Zhang, W., Lee, P.K., Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality (2003) J Immunol, 171, pp. 4927-4933
• Zagzag, D., Amirnovin, R., Greco, M.A., Yee, H., Holash, J., Wiegand, S.J., Al, E., Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis (2000) Lab Invest, 80, pp. 837-849

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------